tiprankstipranks
Crispr Therapeutics proposes to elect Christian Rommel to board of directors
PremiumThe FlyCrispr Therapeutics proposes to elect Christian Rommel to board of directors
1M ago
CRISPR Therapeutics Proposes New Appointment to the Board of Directors
PremiumPress Releases
CRISPR Therapeutics Proposes New Appointment to the Board of Directors
1M ago
Crispr Therapeutics price target raised to $99 from $82 at Mizuho
PremiumThe Fly
Crispr Therapeutics price target raised to $99 from $82 at Mizuho
1M ago
Crispr Therapeutics price target raised to $112 from $110 at Chardan
PremiumThe FlyCrispr Therapeutics price target raised to $112 from $110 at Chardan
2M ago
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
PremiumPress Releases
CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
2M ago
Crispr Therapeutics reports Q4 EPS $1.10, consensus (7c)
PremiumThe Fly
Crispr Therapeutics reports Q4 EPS $1.10, consensus (7c)
2M ago
Cathie Wood’s ARK Investment bought 280K shares of Crispr Therapeutics today
PremiumThe FlyCathie Wood’s ARK Investment bought 280K shares of Crispr Therapeutics today
2M ago
Crispr Therapeutics Secures Funding Through Share Issuance
PremiumCompany Announcements
Crispr Therapeutics Secures Funding Through Share Issuance
2M ago
Crispr Therapeutics announces $280M registered diect offering
PremiumThe Fly
Crispr Therapeutics announces $280M registered diect offering
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100